Team:Ciencias-UNAM

From 2013.igem.org

(Difference between revisions)
 
(17 intermediate revisions not shown)
Line 28: Line 28:
<script src="https://2013.igem.org/Team:Ciencias-UNAM/scripts/jquery?action=raw&ctype=text/javascript"></script>
<script src="https://2013.igem.org/Team:Ciencias-UNAM/scripts/jquery?action=raw&ctype=text/javascript"></script>
-
 
-
 
-
 
-
 
<script src="https://2013.igem.org/Team:Ciencias-UNAM/scripts/beforepagescript?action=raw&ctype=text/javascript"></script>
<script src="https://2013.igem.org/Team:Ciencias-UNAM/scripts/beforepagescript?action=raw&ctype=text/javascript"></script>
Line 435: Line 431:
<div id="u54" class="u54" >
<div id="u54" class="u54" >
-
<div id="u54_rtf"><p style="text-align:left;"><span style="font-family:Arial;font-size:13px;font-weight:normal;font-style:normal;text-decoration:none;color:#666666;">Praesent libero arcu, convallis et dapibus sit amet, aliquet nec nibh. Nulla eu aliquam orci. Phasellus vitae nunc ut urna tincidunt accumsan vel ac dui. Donec tempus quis quam vitae ultrices. Vestibulum congue nec odio eget dictum. Sed tincidunt velit enim. Fusce metus augue, lobortis eget viverra sit amet, fringilla.</span></p></div>
+
<div id="u54_rtf"><p align="justify"><span style="font-family:Arial;font-size:13px;font-weight:normal;font-style:normal;text-decoration:none;color:#666666;">This year's project is an <i>In vivo</i> production of an antimicrobial peptide regulated by <i>quorum sensing</i>. We designed a synthetic system in <i>E. coli</i> to express an antimicrobial peptide (Cathelicidin LL-37) <i>in vivo</i> only in the presence of a quorum sensing molecule (AI-2) and expel it with an efflux pump in order to act against targeted gastrointestinal pathogens.</span></p></div>
</div>
</div>
Line 441: Line 437:
<div id="u55" class="u55" >
<div id="u55" class="u55" >
-
<div id="u55_rtf"><p style="text-align:left;"><span style="font-family:Arial;font-size:13px;font-weight:normal;font-style:normal;text-decoration:none;color:#666666;">Praesent libero arcu, convallis et dapibus sit amet, aliquet nec nibh. Nulla eu aliquam orci. Phasellus vitae nunc ut urna tincidunt accumsan vel ac dui. Donec tempus quis quam vitae ultrices. Vestibulum congue nec odio eget dictum. Sed tincidunt velit enim. Fusce metus augue, lobortis eget viverra sit amet, fringilla.</span></p></div>
+
<div id="u55_rtf"><p align="justify"><span style="font-family:Arial;font-size:13px;font-weight:normal;font-style:normal;text-decoration:none;color:#666666;">We are the team from Facultad de Ciencias, UNAM in Mexico City. Our team brings together students and teachers from all over the country, with various backgrounds and interests.</span></p></div>
</div>
</div>
Line 447: Line 443:
<div id="u56" class="u56" >
<div id="u56" class="u56" >
-
<div id="u56_rtf"><p style="text-align:left;"><span style="font-family:Arial;font-size:13px;font-weight:normal;font-style:normal;text-decoration:none;color:#666666;">Praesent libero arcu, convallis et dapibus sit amet, aliquet nec nibh. Nulla eu aliquam orci. Phasellus vitae nunc ut urna tincidunt accumsan vel ac dui. Donec tempus quis quam vitae ultrices. Vestibulum congue nec odio eget dictum. Sed tincidunt velit enim. Fusce metus augue, lobortis eget viverra sit amet, fringilla.</span></p></div>
+
<div id="u56_rtf"><p align="justify"><span style="font-family:Arial;font-size:13px;font-weight:normal;font-style:normal;text-decoration:none;color:#666666;">We submitted several devices mainly to test and use the following parts:<br><b>Cathelicidin LL-37:</b> An antimicrobial peptide against bacterial infection.<br> <b>MarA:</b> A peptide responsible for an efflux pump in <i>E. coli</i> that is related to its resistance to cathelicidin and similar peptides.</span></p></div>
</div>
</div>
Line 453: Line 449:
<div id="u57" class="u57" >
<div id="u57" class="u57" >
-
<div id="u57_rtf"><p style="text-align:left;"><span style="font-family:Arial;font-size:13px;font-weight:normal;font-style:normal;text-decoration:none;color:#666666;">Praesent libero arcu, convallis et dapibus sit amet, aliquet nec nibh. Nulla eu aliquam orci. Phasellus vitae nunc ut urna tincidunt accumsan vel ac dui. Donec tempus quis quam vitae ultrices. Vestibulum congue nec odio eget dictum. Sed tincidunt velit enim. Fusce metus augue, lobortis eget viverra sit amet, fringilla.</span></p></div>
+
<div id="u57_rtf"><p align="justify"><span style="font-family:Arial;font-size:13px;font-weight:normal;font-style:normal;text-decoration:none;color:#666666;">The project we developed this year yielded several results. We achieved to characterise  and contribute to the iGEM Registry. In this section we present what we think we are our best and main results.</span></p></div>
</div>
</div>
Line 459: Line 455:
<div id="u58" class="u58" >
<div id="u58" class="u58" >
-
<div id="u58_rtf"><p style="text-align:left;"><span style="font-family:Arial;font-size:13px;font-weight:bold;font-style:normal;text-decoration:none;color:#666666;">Read the abstract</span></p></div>
+
<div id="u58_rtf"><p align="justify"><span style="font-family:Arial;font-size:13px;font-weight:bold;font-style:normal;text-decoration:none;color:#666666;">Read the abstract</span></p></div>
</div>
</div>
Line 465: Line 461:
<div id="u59" class="u59" >
<div id="u59" class="u59" >
-
<div id="u59_rtf"><p style="text-align:left;"><span style="font-family:Arial;font-size:13px;font-weight:bold;font-style:normal;text-decoration:none;color:#666666;">Meet the team</span></p></div>
+
<div id="u59_rtf"><p align="justify;"><span style="font-family:Arial;font-size:13px;font-weight:bold;font-style:normal;text-decoration:none;color:#666666;">Meet the team</span></p></div>
</div>
</div>
Line 471: Line 467:
<div id="u60" class="u60" >
<div id="u60" class="u60" >
-
<div id="u60_rtf"><p style="text-align:left;"><span style="font-family:Arial;font-size:13px;font-weight:bold;font-style:normal;text-decoration:none;color:#666666;">Read more...</span></p></div>
+
<div id="u60_rtf"><p align="justify"><span style="font-family:Arial;font-size:13px;font-weight:bold;font-style:normal;text-decoration:none;color:#666666;">Read more...</span></p></div>
</div>
</div>
Line 477: Line 473:
<div id="u61" class="u61" >
<div id="u61" class="u61" >
-
<div id="u61_rtf"><p style="text-align:left;"><span style="font-family:Arial;font-size:13px;font-weight:bold;font-style:normal;text-decoration:none;color:#666666;">Read more...</span></p></div>
+
<div id="u61_rtf"><p align="justify"><span style="font-family:Arial;font-size:13px;font-weight:bold;font-style:normal;text-decoration:none;color:#666666;">Read more...</span></p></div>
</div>
</div>
Line 573: Line 569:
<div id="u75_rtf"><p style="text-align:left;"><span style="font-family:Arial;font-size:28px;font-weight:bold;font-style:normal;text-decoration:none;color:#4B4F54;">News from the lab</span></p></div>
<div id="u75_rtf"><p style="text-align:left;"><span style="font-family:Arial;font-size:28px;font-weight:bold;font-style:normal;text-decoration:none;color:#4B4F54;">News from the lab</span></p></div>
-
 
+
<br>
 +
<a class="twitter-timeline" data-dnt="true" href="https://twitter.com/iGEM_Ciencias" data-widget-id="380869964040638464">Tweets by @iGEM_Ciencias</a>
 +
<script>!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?'http':'https';if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+"://platform.twitter.com/widgets.js";fjs.parentNode.insertBefore(js,fjs);}}(document,"script","twitter-wjs");</script>
</div>
</div>
<div id="u76" class="u76" >
<div id="u76" class="u76" >
-
<div id="u76_rtf"><p style="text-align:left;"><span style="font-family:Arial;font-size:28px;font-weight:bold;font-style:normal;text-decoration:none;color:#4B4F54;">Gallery</span></p></div>
+
<div id="u76_rtf"><p style="text-align:left;"><span style="font-family:Arial;font-size:28px;font-weight:bold;font-style:normal;text-decoration:none;color:#4B4F54;">Gallery</span></p></div>  
-
<br>
+
<br> <!-- SnapWidget -->
-
<!-- www.intagme.com -->
+
<iframe src="http://snapwidget.com/in/?u=aWdlbV9jaWVuY2lhc3xpbnwxMDB8M3wyfHx5ZXN8NXxub25lfG9uU3RhcnR8eWVz&v=19913" allowTransparency="true" frameborder="0" scrolling="no" style="border:none; overflow:hidden; width:345px; height: 230px" ></iframe>
-
<iframe src="http://www.intagme.com/in/?u=aWdlbV9jaWVuY2lhc3xpbnwxMDB8M3wzfHx5ZXN8NXx1bmRlZmluZWQ=" allowTransparency="true" frameborder="0" scrolling="no" style="border:none; overflow:hidden; width:345px; height: 345px" ></iframe>
+
-
 
+
</div>
</div>

Latest revision as of 04:20, 28 September 2013

Home

HOME

PROJECT

HUMAN PRACTICES

TEAM

SAFETY

THE PROJECT

THE PEOPLE

PARTS

ACHIEVEMENTS

This year's project is an In vivo production of an antimicrobial peptide regulated by quorum sensing. We designed a synthetic system in E. coli to express an antimicrobial peptide (Cathelicidin LL-37) in vivo only in the presence of a quorum sensing molecule (AI-2) and expel it with an efflux pump in order to act against targeted gastrointestinal pathogens.

We are the team from Facultad de Ciencias, UNAM in Mexico City. Our team brings together students and teachers from all over the country, with various backgrounds and interests.

We submitted several devices mainly to test and use the following parts:
Cathelicidin LL-37: An antimicrobial peptide against bacterial infection.
MarA: A peptide responsible for an efflux pump in E. coli that is related to its resistance to cathelicidin and similar peptides.

The project we developed this year yielded several results. We achieved to characterise and contribute to the iGEM Registry. In this section we present what we think we are our best and main results.

Read the abstract

Meet the team

Read more...

Read more...

News from the lab


Gallery